Alternative Names:

APOA1; MGC117399; Apo-AI; ApoA-I; APOAI; Apolipoprotein A1;

Application:

WB IHC ICC/IF IP

Reactivity:

Human Mouse

Dilution:

WB 1:5000~1:10000 IHC 1:50~1:200 ICC/IF 1:50~1:200 IP 1:50

	Western blot analysis of Apolipoprotein A1 expression in HepG2 cell lysate.

Purification:

Affinity-chromatography

Specificity:

Apolipoprotein A1 Antibody detects endogenous levels of Apolipoprotein A1

Immunogen:

A synthesized peptide derived from human Apolipoprotein A1

Description:

ApoAI (Apolipoprotein A1) is a major component of high density lipoprotein (HDL, the “good cholesterol”) in plasma. It is produced in the liver and small intestine. ApoA1 is a cofactor for lecithin cholesterolacyltransferase (LCAT) that is responsible for the formation of plasma cholesteryl esters and promotes cholesterol efflux from tissues to the liver for excretion.

Storage Condition and Buffer:

Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at +4°C short term. Store at -20°C long term. Avoid freeze / thaw cycle.